Abstract: Seroma formation is the most prevalent postoperative sequela after breast cancer surgery. A total of 263 aspirations of seroma fluid in 42 patients were performed after mastectomy; cytokines were measured in 148 cases. The concentration of interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-12p70 (IL-12) and tumor necrosis factor (TNF) were measured. The patients underwent 9.0 seroma aspirations on average (range 1-17) during an average of 30.7 days (range 7-72). The average cumulative seroma volume was 2056.1 mL (range 50-5130). In all samples, the maximal average concentrations of IL-6 (mean 10717 pg/mL, range 136-100000) and IL-8 (mean 7221 pg/mL, range 102-79828) were 55-200-fold above the serum/plasma levels of asymptomatic adults. In contrast, we observed levels similar to normal serum/plasma levels for IL-1 (mean 62.8 pg/mL, range 0-1226), IL-10 (mean 29.8 pg/mL, range 3.6-359), and lower-than-normal serum/plasma levels of TNF (mean 3.4 pg/mL, range 0-31.7) and IL-12 (mean 0.5 pg/mL, range 0-11.8). Patients with clinical infection had generally significant higher maximal IL-6 (p = 0.004) and IL-8 (0.019) than patients without clinical infection. However, most patients had no bacterial infection. None of the cytokines were associated with cumulative seroma volume, duration of seroma production or number of seroma aspirations. Seroma formation after mastectomy has a pro-inflammatory component, as indicated by the high levels of interleukin-6 and interleukin-8. However, these levels do not predict the course of seroma production.
INTRODUCTION
Seroma, an accumulation of fluid, can infrequently occur after any surgical procedure and is the most prevalent postoperative sequela after breast surgery, with an incidence of 10% to 85%, leading to significant morbidity and discomfort and possibly delaying adjuvant therapy [1] . Different causes of seroma have been proposed, such as the disruption of lymphatic drainage with fibrinolysis, or the surgical technique, especially the use of electrocautery versus knife dissection [2, 3] . Several interventions have been attempted, including the use of tranexamic acid, bovine thrombin application, fibrin glue, avoiding drainage, postoperative arm activity and altering the surgical technique [4] . The origin of seroma remains unclear and no generally accepted preventive or curative method exists [1] . Identification of the causal mechanisms of seroma formation could guide evidence-based treatment. As the name indicates, seroma has traditionally been looked upon as an accumulation of lymph or serum, as repeated recently [5] . Watt-Boolsen et al. concluded that seroma formation was a result of an inflammatory process determined by the cell type and proteins in seroma fluid [6] , and this has been confirmed recently [7] . In wound repair, various cells release cytokines, chemokines, and growth factors, which all have the potential to promote seroma formation [8] . Based on the *Address correspondence to this author at the Department of Clinical Biochemistry, Gentofte Hospital, University of Copenhagen, Denmark; Tel: +46-46-173655; Fax: +46-46-130064; E-mail: pal.szecsi@med.lu.se notion that an inflammatory process contributes to seroma formation, in this paper, we evaluate the cytokine profile in seroma fluid after surgery for primary breast carcinoma. Furthermore, the study investigates whether the cytokine concentration reflects the likelihood of seroma development.
MATERIAL AND METHODS

Study Group and Surgical Technique
Between March and May 2007, patients who developed seroma after surgery for primary breast cancer were investigated. Mastectomy or wide local excision was performed with diathermy and sharp dissection in the axilla. The axillary dissection consisted of sentinel lymph node biopsy or axillary clearance of level I or II or both. All patients had a single closed suction drain inserted through the medial end of the incision. The drain was removed when the daily volume was below 100 ml or after a maximum of five days. In case of seroma production, the patients were received in the out-patient clinic and were aspirated by specially trained nurses until the seroma volume was estimated to be below 50 ml. The wound was evaluated for infection and necrosis at every visit. The amount of drainage fluid, seroma volume, number of punctures and the presence of any complication was recorded. Wound infection was defined as redness with or without purulent seroma fluid. In case of symptoms of clinical infection, a culture for bacteria was performed.
Ethics
The study was performed in accordance with the Helsinki Declaration, and was approved by The Committees on Biomedical Research Ethics of the Capital Region of Denmark (H-D-2007-0006) and the Danish Data Protection Agency. All participants provided informed written consent.
Cytokine Measurement
The seroma aspirate was kept at 5º C until the end of the day of aspiration. Aliquots were stored at -80º C until analysis in batch. The cytokines interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-12p70 (IL-12) and tumor necrosis factor (TNF) were quantified by multiplex microsphere beads #551811 (BD Biosciences, San Jose, CA, USA) according to the manufacturer's instructions with minor modifications. More than 300 of each bead type were analyzed on a FACSCanto II flow cytometer (BD) at a low flow rate. Data were transformed to FCS2 format and analyzed with FCAP Array V1.0 software (Soft Flow, Pecs, Hungary) using the median fluorescence parameter 2 (FL2). The assay is traceable to NIST/WHO standards 86/680 (IL-1, factor 0.78), 89/548 (IL-6, factor 0.96), 89/520 (IL-8, factor 1.26), and 92/513 (IL-10, factor 1.91), 95/544 (IL-12, factor 1.28) and 87/650 (TNF, factor 0.90). The limit of detection is 7.2 pg/mL (IL-1), 2.5 pg/mL (IL-6), 3.6 pg/mL (IL-8), 3.3 pg/mL (IL-10), 1.9 pg/mL (IL-12) and 3.7 pg/mL (TNF).
Statistical Analysis
Groups were compared using a one-way analysis of variance (ANOVA). Levene's test for homogeneity of variance and post-hoc analyses with Dunnett's C or GamesHowell, assuming unequal variances and group sizes, were used to investigate the nature of any differences. Dichotomous logistic regression models were performed to analyze the duration of seroma production (<30 days, >=30 days), cumulative seroma volume (<750 ml, >=750 ml), and number of seroma punctuations (<7 times, >=7 times), respectively, as the dependent variables, and with maximal normalized transformed values of IL-1 (1/x), IL-6 (ln), IL-8 (ln), IL-10(ln), IL-12 (sqrt), TNF (ln), as well as gender, BMI, surgical procedure, and infection (yes/no) as the independent variables. Associations were expressed as odds ratios with 95% confidence intervals. In multivariate analysis, only the variables found to be significant in the univariate analysis were used. A value of p<0.05 was considered to be statistically significant. Data analyses were performed using the Statistical Products and Service Solutions package (SPSS Inc., Chicago, IL, USA) for Windows (release 15.0).
RESULTS
The details of the 42 patients with seroma formation are presented in Table 1 . A total of 263 seroma aspirations were performed; cytokines were measured in 148 cases. The patients underwent 9.0 seroma aspirations on average (range 1-17) during an average of 30.7 days (range 7-72). The average cumulative seroma volume was 2056.1 mL (range 50-5130). In all samples, the maximal average concentrations of IL-6 (mean 10717 pg/mL, range 136-100000) and IL-8 (mean 7221 pg/mL, range 102-79828)
were 55-200-fold above the serum/plasma levels of asymptomatic adults [9] . In contrast, we observed levels similar to normal serum/plasma levels for IL-1 (mean 62.8 pg/mL, range 0-1226), IL-10 (mean 29.8 pg/mL, range 3.6-359), and lower-than-normal serum/plasma levels of TNF (mean 3.4 pg/mL, range 0-31.7) and IL-12 (mean 0.5 pg/mL, range 0-11.8). The maximal concentrations of IL-6 and IL-8 did correlate (2-tailed Spearman's rho=0.838, p<0.0001), but not with any of the other cytokines. None of the normalized transformed variables for the cytokines were associated with cumulative seroma volume (p= 0.122-0.643), duration of seroma production (p=0.138-0.690) or number of seroma aspirations (p=0.068-0.618).
Only IL-8 showed statistically significant associations (p=0.009) with seroma formation in a model with all the cytokines, but this was not the case in a solitary model (p=0.555). None of the registered variables ( Table 1) could predict the course of seroma production. A tendency of correlation between lower IL-6 and IL-8 values and a longer duration of seroma production was observed (Fig. 1) ; however, some patients abruptly stopped producing more fluid in spite of very high levels a few days previously. Patients with clinical infection had generally significant higher maximal IL-6 (p = 0.004) and IL-8 (0.019) than patients without clinical infection (Fig. 2) . Patients with cumulative seroma production >= 750mL had significant higher IL-6 (p = 0.001) and IL-8 (p = 0.0001) in patients with than without clinical infection. These differences were not present in patients with low seroma production. Patients with >= 7 seroma aspiration had significant higher Il-6 (p = 0.003) and Il-8 (p = 0.004) in patients with than without clinical infection, whereas only IL-8 were higher in patients with < 7 seroma aspiration (p = 0.024). Similarly, patients with longer seroma duration than 30 days had significant higher Il-6 (p = 0.002) and Il-8 (p = 0.024) in patients with than without clinical infection, whereas only IL-8 were higher in patients with < 30 days seroma duration (p = 0.036). Interestingly, in the 13 patients with signs of clinical infection, no growth was observed in six of the nine cases were bacterial culture were performed ( Table 1) . Three cases all revealed Staphylococcus aureus growth in spare to abundant amount.
DISCUSSION
Most breast cancer patients develop low-volume seroma after surgery; often lasting many weeks [10] . In our group of patients that required at least one aspiration, 21 patients (50%) produced >=750 mL, 16 patients (38.1%) underwent >= 7 aspirations and 17 patients (40.5%) had a prolonged duration of >=30 days.
The previous notion that seroma after breast surgery is derived from lymph is debatable. Watt-Boolsen et al. investigated drainage fluid during the first 3 days after radical mastectomy in 19 women that developed seroma and in eight women that did not [6] . They found a significant higher concentration of granulocytes than lymphocytes in women with seroma as well as a significant higher concentration of lymphocytes than granulocytes in women without seroma. On the other hand, did Montalto et al. report a preferential lymphocyte percentage (58-94%) compared to 0.1-44% granulocytes in 11 seroma samples from seven patients, but did not provide the total concentrations [5] . Lymph fluid is characterized by about 95% dominance of lymphocytes as seen in the thoracic duct [11, 12] . We did not measure leucocytes in the aspirates, but most were rather clear indicating a low concentration of cells. In a few cases with persisting seroma formation, endoscopic exploration has revealed a nearly serous lined seroma cavity. This is consisting with the immunohistochemical observation of especially CD3 and CD20 lymphocytes, and CD68 macrophages in the postmatectomy seroma beds [13] . In conclusion, it seems unlike that lymph is the source of seroma, however it cannot be ruled out that some lymph spillage occur, especially just after surgery. Also the level of cytokines points away from viewing seroma as lymph. Postnodal lymph in normal rats has very low concentrations of IL-6, which is much lower than the concentration observed here. Rat lymph has similarly low concentrations of IL-1, IL-10 and TNF as we observed in human seroma fluid [14] . Olszewski et al. measured several cytokines in lymph drained from the joints of rheumatoid arthritis patients and from control subjects [15] . They found higher level of e.g. IL-6 and Il-8 in lymph compared to serum in both patients and control, but both at much lower levels than we observed in seroma fluid. Interestingly, the patients generally had higher levels of many cytokines in both lymph and serum, indicating a general inflammatory state. However, if these findings are comparable with seroma formation is questionable, as rheumatoid arthritis is a chronic autoimmune condition.
Purulent infection is characterized by accumulation of leucocytes, which secrete a variety of cytokines. Our patients with symptoms of clinical infection had generally significant higher maximal IL-6 and IL-8 than patients without clinical infection (Fig. 1) . However, this did not reflect bacterial growth. Most of the patients with clinical infection had no bacterial growth in culture of seroma fluid, indicting an aseptic inflammation ( Table 1) . Even though some of the highest maximal levels of cytokines were observed in patients with positive bacterial culture, this was not the obvious in all cases. If clinical infection/inflammation triggers the elevation of cytokines, one might expect an increase in cytokine concentration around the time of infection. This is not pronounced, neither for patients with clinical infection with (KF) nor without (DV) bacterial growth, as exemplified in Fig. (3) . It should be noted that the maximal levels of cytokines (IL-6 and IL-8) were about 10 times higher in the patient with abundant Staphylococcus aureus infection, but a great variation among the patients was observed. In addition to leucocyte cytokines may be produced by a variety of different cell types. For example is IL-6 produced by fibroblasts, endothelial smooth muscle cells, chondrocytes, osteoblasts, and keratinocytes. Our results do not provide any information about the source of the cytokines in seroma fluid and they may originate from any of the above mentioned cells. Several other factors indicate that seroma production after mastectomy is an inflammatory process. In a rat mastectomy model, Kocdor et al. showed that the immunomodulating 5-fluorouracil was highly effective in preventing seroma formation [16] . In humans, similar high concentrations of IL-6 as ours were observed in wound fluid up to 3 days after mastectomy [17] . The authors also reported high concentrations of other growth factors especially transforming growth factor beta (TGF-) and tissue inhibitor of metalloproteinase 1 (TIMP-1). Loo et al. also reported elevated IL-6 during the first 5 days after mastectomy but at a lower concentration [18] . The authors did not observe elevated levels of TIMP-1. The discrepancy may be due to differences in analytic methods and the lack of standardization. Their findings are in accordance with the cytokine-mediated pro-inflammation that has been reported after a posterior cervical decompression, where high levels of IL-6 and IL-8 were observed [19] . Here, levels of other pro-inflammatory cytokines such as monocyte chemotactic protein-1 (MCP-1) were elevated, as were levels of antiinflammatory cytokines TGF-1, TGF-2, and TGF-3 but not IL-10. Yilmaz et al. compared the use of a scalpel, electrocautery and ultrasonic dissection during mastectomy [20] . Interesting, electrocautery induced significantly higher levels of cytokines than scalpel and ultrasonic dissection. The authors measured IL-6 and TNF in drain fluid within 24 h after surgery. Somewhat elevated IL-6 and TNF levels were observed. The latter is a bit puzzling and represents a discrepancy with our results. TNF stimulates the acute-phase reaction and pro-inflammatory cytokines IL-6 and IL-8. However, the present observation of high concentrations of IL-6, the most important mediators of fever and the acutephase response, and IL-8, the major mediator of the inflammatory response, clearly indicate that seroma formation has an inflammatory component. We only observed elevations in early pro-inflammatory cytokines and no elevation in anti-inflammatory cytokines. The latter is not seen even at the end of seroma production. Whether the elevated cytokines is a causal effect is unclear. In contrast to the effect of 5-fluorouracil in the rat model, a single prophylactic intravenous dose of steroid preoperatively at mastectomy did not diminish seroma formation in humans [21] . The lack of immune suppression of the steroid could be because no sustained release formula was used or because the dose was too small. In contrast, Taghizadeh et al. demonstrated a significant reduction of seroma formation when steroid was administered into the cavity at the site of seroma puncture [22] . Rogliani et al. demonstrated reduced seroma production after steroid injections in the extended latissimus dorsi donor site after reconstructive surgery [23] .
CONCLUSION
In conclusion, seroma formation after mastectomy most likely is a pro-inflammatory process, as indicated by the very high levels of IL-6 and IL-8. However, these levels do not predict the cause of seroma production. Our findings and recent reports indicate that inhibiting inflammation might be a plausible preventive treatment.
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